87 related articles for article (PubMed ID: 9610462)
1. Inducing labor with a sustained-release PGE2 vaginal insert. Experience at a community hospital.
Blair FC; Tassone SA; Pearman CR; St Cyr MB; Rayburn WF
J Reprod Med; 1998 May; 43(5):408-12. PubMed ID: 9610462
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial of vaginal prostaglandin E2 for induction of labor. Insert vs. tablet.
Rabl M; Joura EA; Yücel Y; Egarter C
J Reprod Med; 2002 Feb; 47(2):115-9. PubMed ID: 11883349
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy and safety of vaginal misoprostol versus dinoprostone vaginal insert in labor induction at term: a randomized trial.
Ozkan S; Calişkan E; Doğer E; Yücesoy I; Ozeren S; Vural B
Arch Gynecol Obstet; 2009 Jul; 280(1):19-24. PubMed ID: 19034471
[TBL] [Abstract][Full Text] [Related]
4. Mode of delivery in pregnancies with premature rupture of membranes at or before term following induction of labor with vaginal prostaglandin E2.
Ben-Haroush A; Yogev Y; Glickman H; Bar J; Kaplan B; Hod M
Am J Perinatol; 2004 Jul; 21(5):263-8. PubMed ID: 15232758
[TBL] [Abstract][Full Text] [Related]
5. Uterine rupture with the use of PGE2 vaginal inserts for labor induction in women with previous cesarean sections.
Taylor DR; Doughty AS; Kaufman H; Yang L; Iannucci TA
J Reprod Med; 2002 Jul; 47(7):549-54. PubMed ID: 12170531
[TBL] [Abstract][Full Text] [Related]
6. Retention of dinoprostone vaginal insert beyond 12 hours for induction of labor.
Brennan MC; Pevzner L; Wing DA; Powers BL; Rayburn WF
Am J Perinatol; 2011 Jun; 28(6):479-84. PubMed ID: 21225563
[TBL] [Abstract][Full Text] [Related]
7. [Uterine hyperstimulation following cervix ripening with dinoprostone in a vaginal insert system].
Brouwers JM; Briët JW; Brouwers JR
Ned Tijdschr Geneeskd; 2004 Jun; 148(26):1300-3. PubMed ID: 15279216
[TBL] [Abstract][Full Text] [Related]
8. Uterine rupture after use of a prostaglandin E2 vaginal insert during vaginal birth after cesarean. A report of two cases.
Raskin KS; Dachauer JD; Doeden AL; Rayburn WF
J Reprod Med; 1999 Jun; 44(6):571-4. PubMed ID: 10394556
[TBL] [Abstract][Full Text] [Related]
9. [Controlled release vaginal dinoprostone for the induction of labour].
Cipriano L; Brosio F; Pacifici E; Berta S; Meloni P; Pace S; Palazzetti PL; Anceschi MM
Minerva Ginecol; 2003 Aug; 55(4):367-72. PubMed ID: 14581863
[TBL] [Abstract][Full Text] [Related]
10. Induction of labour: a comparison between controlled-release dinoprostone vaginal pessary (Cervidil) and dinoprostone intravaginal gel (Prostin E2).
Kho EM; Sadler L; McCowan L
Aust N Z J Obstet Gynaecol; 2008 Oct; 48(5):473-7. PubMed ID: 19032662
[TBL] [Abstract][Full Text] [Related]
11. Misoprostol vaginal insert compared with dinoprostone vaginal insert: a randomized controlled trial.
Wing DA;
Obstet Gynecol; 2008 Oct; 112(4):801-12. PubMed ID: 18827122
[TBL] [Abstract][Full Text] [Related]
12. [Intravaginal PgE2 administration for inducing labor in premature rupture of fetal membranes].
Schaetti D; Blumer D; Dutar N; Gaudenz R; Hugentobler W
Geburtshilfe Frauenheilkd; 1991 Jan; 51(1):23-6. PubMed ID: 2026296
[TBL] [Abstract][Full Text] [Related]
13. Plasma prostaglandin E(2) metabolite levels during labor induction with a sustained-release prostaglandin E(2) vaginal insert.
Goharkhay N; Stanczyk FZ; Gentzschein E; Wing DA
J Soc Gynecol Investig; 2000; 7(6):338-42. PubMed ID: 11111068
[TBL] [Abstract][Full Text] [Related]
14. Controlled-release misoprostol vaginal insert in parous women for labor induction: a randomized controlled trial.
Ewert K; Powers B; Robertson S; Alfirevic Z
Obstet Gynecol; 2006 Nov; 108(5):1130-7. PubMed ID: 17077234
[TBL] [Abstract][Full Text] [Related]
15. Indicated labor induction with vaginal prostaglandin E2 increases the risk of cesarean section even in multiparous women with no previous cesarean section.
Ben-Haroush A; Yogev Y; Bar J; Glickman H; Kaplan B; Hod M
J Perinat Med; 2004; 32(1):31-6. PubMed ID: 15008383
[TBL] [Abstract][Full Text] [Related]
16. A prospective randomized study comparing misoprostol and oxytocin for premature rupture of membranes at term.
Zeteroğlu S; Engin-Ustün Y; Ustün Y; Güvercinçi M; Sahin G; Kamaci M
J Matern Fetal Neonatal Med; 2006 May; 19(5):283-7. PubMed ID: 16753768
[TBL] [Abstract][Full Text] [Related]
17. [Uterine reactions to prostaglandins in induced labor--results of a multicenter study].
Mink D; Heiss C; Rath W; Schmidt W
Zentralbl Gynakol; 1995; 117(1):35-9. PubMed ID: 7879461
[TBL] [Abstract][Full Text] [Related]
18. Use of misoprostol for cervical ripening.
Katz VL; Farmer RM; Dean CA; Carpenter ME
South Med J; 2000 Sep; 93(9):881-4. PubMed ID: 11005347
[TBL] [Abstract][Full Text] [Related]
19. Induction of labor with prostaglandin E2 in women with previous cesarean section and unfavorable cervix.
Yogev Y; Ben-Haroush A; Lahav E; Horowitz E; Hod M; Kaplan B
Eur J Obstet Gynecol Reprod Biol; 2004 Oct; 116(2):173-6. PubMed ID: 15358459
[TBL] [Abstract][Full Text] [Related]
20. A comparison of spontaneous labor with induced vaginal tablets prostaglandin E2 in grand multiparae.
Sobande AA; Al-Bar HM; Archibong EI
Saudi Med J; 2001 Aug; 22(8):698-701. PubMed ID: 11573116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
